Patheon Can't Duck JV Partner's Suit Over $255M Acquisition

Law360, New York (February 25, 2013, 8:04 PM EST) -- A Florida federal judge said Friday that Procaps SA can contest joint venture partner Patheon Inc.'s $255 million acquisition of a pharmaceutical company, shooting down Patheon's argument that Procaps actually stood to benefit from the deal's alleged anti-competitive impacts.

U.S. District Judge Donald L. Graham ruled that Procaps — which previously agreed to collaborate with Patheon on development of a softgel capsule service for pharmaceutical products — had standing to bring its complaint under antitrust laws, according to an order. Procaps alleged in the suit that...
To view the full article, register now.